Niaid preclinical development support - production of ECD-IG protein

Ended Awarded Last action

Contract number
HHSN27200029
Awardee
Awarding agency
Obligated
$7,214,107

Award facts

Contract value 76% obligated
  • $7,214,106.71 Current, with exercised options
  • $9,469,447.71 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$712,340
Other Administrative Action P00008 $0
Change Order P00007 $0
Funding Only Action P00006 $955,917
Funding Only Action P00005 -$0
Other Administrative Action P00004 -$33,600
Change Order P00003 $198,916
Change Order 2 $0
Definitize Change Order 1 · Niaid preclinical development support - production of ECD4-IG protein $374,069
Original award $6,431,145

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 17, 2015, with a ceiling value of $9,469,447.71 for preclinical development support including production of ECD-IG and ECD4-IG proteins and toxicity testing for HIV proteins.

Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with no set-aside. The ultimate completion date is January 31, 2024.

Service Contract Inventory data shows the order's labor footprint declined over its active period. FY2021 recorded $621 thousand invoiced across 0.3 FTEs and 660 contractor hours at $940.43 per hour. FY2022 peaked at 0.8 FTEs and 1,573 contractor hours generating $260 thousand invoiced at $165.12 per hour. By FY2024, activity had substantially contracted to 67 contractor hours and $21 thousand invoiced at $307.60 per hour, with no FTE allocation. The prime self-performed all reported work with no subcontractors reported across the measured period.

Quick answers

Who was awarded contract HHSN27200029?

HHSN27200029 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 17, 2015.

How much is contract HHSN27200029 worth?

The government has obligated $7,214,107 on HHSN27200029. Its potential value, with all options, is $9,469,448.

Is contract HHSN27200029 an order under another contract?

Yes. HHSN27200029 is a delivery order under HHSN272201100021I, an indefinite delivery contract.

Was contract HHSN27200029 competed?

The extent of competition for HHSN27200029 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award